Orcasonix

Company Overview

Snapshot

Founded in January 2011 by Mati Shirizly, Orcasonix operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing its core technology. Orcasonix has commenced clinical trials for its initial product, demonstrating progress in its development pipeline.

Business overview

Orcasonix is a Health Tech & Life Sciences company developing a novel ultrasound imaging system based on its proprietary O-mode technology. This technology aims to provide depth-independent resolution at significant depths, regardless of body habitus, while enabling low-cost hardware implementation with a high number of channels. The company's platform is designed to support a family of high-quality, cost-efficient products, targeting direct end-user applications and OEM integration within the medical devices and diagnostics devices sectors.

Company Intelligence Q&A

What is Orcasonix's primary technological innovation?

Orcasonix is developing an ultrasound imaging system based on its proprietary O-mode technology, which offers depth-independent resolution and aims for highly cost-efficient hardware implementation with a virtually unlimited number of channels.

What stage of development is Orcasonix's initial product in?

Orcasonix's first product, based on its O-mode technology, has commenced clinical trials, with other products in early stages of development.

What markets or applications does Orcasonix target with its technology?

Orcasonix's technology is suitable for direct end-user applications in healthcare as well as for OEM implementation by manufacturers of existing medical imaging products.

Who founded Orcasonix?

Orcasonix was co-founded by Mati Shirizly, who also serves as the CEO.

What is the current operational status of Orcasonix?

Orcasonix ceased to operate in August 2017 and is currently in a Non-Active status.